
无数据
无数据
无数据
| CAS Number | 68-35-9 |
| Catalog Number | AG00IBRY(AGN-PC-0WAF2O) |
| Chemical Name | Sulfadiazine |
| EC Number | 200-685-8 |
| IUPAC Name | 4-amino-N-pyrimidin-2-ylbenzenesulfonamide |
| InChI | InChI=1S/C10H10N4O2S/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10/h1-7H,11H2,(H,12,13,14) |
| InChI Key | SEEPANYCNGTZFQ-UHFFFAOYSA-N |
| MDL Number | MFCD00006065 |
| Molecular Formula | C10H10N4O2S |
| Molecular Weight | 250.2770 |
| SMILES | O=S(C1=CC=C(N)C=C1)(NC2=NC=CC=N2)=O |
| UNII | 0N7609K889 |
| Synonyms | Sulfadiazine,
Sulfadiazine, Zinc,
Sulfazin,
Sulfazine,
Sulphadiazine,
Zinc Sulfadiazine,
sulfadiazine,
Sulphadiazine,
68-35-9,
Sulfapyrimidine,
Sulfadiazin,
Sulfazine,
Sulfadiazene,
Liquadiazine,
Sulfapyrimidin,
Adiazin,
Adiazine,
Debenal,
Pyrimal,
2-Sulfanilamidopyrimidine,
Cremodiazine,
Spofadrizine,
Theradiazine,
Cremotres,
Deltazina,
Diazolone,
Eskadiazine,
Microsulfon,
Neotrizine,
Palatrize,
Piridisir,
Quadetts,
Quadramoid,
Sanodiazine,
Sterazine,
Sulfatryl,
Sulfolex,
Sulfonsol,
Terfonyl,
Trifonamide,
Truozine,
Diazin,
Diazyl,
Neazine,
Pirimal,
Sulfose,
Trisem,
Sulfanilamidopyrimidine,
Honey diazine,
Lipo-Levazine,
Tri-Sulfameth,
Triple Sulfas,
Coco-Diazine,
Lipo-Diazine,
Metha-Meridiazine,
Sulfadiazinum,
Diazovit,
Sulfadiazina,
Sulphadiazine E,
Sulfapirimidin,
Di-Azo-Mul,
Thi-Di-Mer,
2-Sulfanilylaminopyrimidine,
Codiazine,
Silvadene,
Pecta-diazine, suspension,
Benzenesulfonamide, 4-amino-N-2-pyrimidinyl-,
CocoDiazine,
Solfadiazina [DCIT],
RP 2616,
4-amino-N-(pyrimidin-2-yl)benzenesulfonamide,
Pyrimidine, 2-sulfanilamido-,
2-Sulfanilamidopyrimidin,
Sulfapyrimidin [German],
2-Sulfapyrimidine,
Sulfonamides Duplex,
Sulfadiazinum [INN-Latin],
Sulfadiazina [INN-Spanish],
4-AMINO-N-2-PYRIMIDINYLBENZENESULFONAMIDE,
Zinc Sulfadiazine,
N(1)-2-pyrimidylsulfanilamide,
N(1)-2-pyrimidinylsulfanilamide,
2-Sulfanilamidopyrimidin [German],
S.N. 112,
4-amino-N-pyrimidin-2-ylbenzenesulfonamide,
A 306,
A-306 (VAN),
N(sup 1)-2-Pyrimidinylsulfanilamide,
MFCD00006065,
Thermazene,
N1-2-Pyrimidinylsulfanilamide,
Sildaflo,
CHEBI:9328,
Sulfanilamide, N(sup 1)-2-pyrimidinyl-,
N(sup1)-2-Pyrimidylsulfanilamide,
Sulfanilamide, N1-2(1H)-pyrimidinylidene-,
4-Amino-N-(2-pyrimidinyl)benzenesulfonamide,
4-amino-N-pyrimidin-2-yl-benzenesulfonamide,
N1-(Pyrimidin-2-yl)sulfanilamide,
Sulfanilamide, N1-2-pyrimidinyl-,
UNII-0N7609K889,
A-306,
N(sup1)-2-Pyrimidinylsulfanilamide,
EINECS 200-685-8,
NSC 35600,
4-amino-N-(pyrimidin-2-yl)benzene-1-sulfonamide,
CHEMBL439,
N1-2-Pyrimidylsulfanilamide,
BRN 0235192,
C10H10N4O2S,
Triple sulfa,
4-Amino-N-2-pyrimidinyl-benzenesulfonamide,
AI3-01047,
S. N. 112,
SEEPANYCNGTZFQ-UHFFFAOYSA-N,
N(1)-(2-Pyrimidinyl)sulfanilamide,
NSC35600,
CAS-68-35-9,
NCGC00016305-01,
Solfadiazina,
0N7609K889,
[(4-aminophenyl)sulfonyl]pyrimidin-2-ylamine,
NSC117870,
Pecta-Diazine,
SMR000059113,
Sulfadiazine (TN),
N-(2-Pyrimidinyl)sulfanilamide,
Sulfadiazine [USAN:INN:JAN],
rBPI21 & Sulfa,
SR-01000002973,
SSD,
2-Sulfanilamido-pyrimidine,
CRL-8131 & Sulfadiazine,
Sulfadiazine (JAN/USP/INN),
Sulfadiazine,(S),
Trisulfapyrimidine, oral suspension,
Sulfadiazine [USP:INN:BAN:JAN],
DRG-0214,
Prestwick_428,
Spectrum_000986,
Sulfadiazina Reig Jofre,
Sulfacombin (Salt/Mix),
AC1L1JUR,
Prestwick0_000023,
Prestwick1_000023,
Prestwick2_000023,
Prestwick3_000023,
Spectrum2_001319,
Spectrum3_001362,
Spectrum4_000342,
Spectrum5_000992,
Epitope ID:140083,
AC1Q51XM,
AC1Q6W1E,
Sulfadiazine, >=99.0%,
DSSTox_CID_24130,
DSSTox_RID_80105,
DSSTox_GSID_44130,
Oprea1_081078,
SCHEMBL24176,
BSPBio_000085,
BSPBio_002884,
KBioGR_000743,
KBioSS_001466,
5-25-10-00067 (Beilstein Handbook Reference),
MLS000069423,
MLS006011457,
DivK1c_000543,
SPECTRUM1500546,
SPBio_001417,
SPBio_002006,
BPBio1_000095,
WLN: T6N CNJ BMSWR DZ,
DTXSID7044130,
CTK7D7930,
HMS501L05,
KBio1_000543,
KBio2_001466,
KBio2_004034,
KBio2_006602,
KBio3_002104,
NINDS_000543,
HMS1568E07,
HMS1921A13,
HMS2090P09,
HMS2092I15,
HMS2095E07,
HMS2235D19,
HMS3371L19,
HMS3655I10,
HMS3712E07,
Pharmakon1600-01500546,
ZINC120319,
ALBB-014888,
BCP12140,
HY-B0273,
Tox21_110360,
BBL013169,
BDBM50166571,
CCG-39257,
NSC-35600,
NSC757324,
Recombinant bactericidal/permeability-increasing protein & Sulfadiazine,
s1770,
SBB007604,
SBB057674,
STK317797,
2-(p-Aminobenzenesulfonamido)pyrimidin,
AKOS000119073,
CS-2263,
DB00359,
KS-1144,
MCULE-4577338719,
NE10425,
NSC-757324,
RP17586,
2-(4-Aminobenzenesulfonamido)pyrimidine,
4-amino-N-2-pyrimidylbenzenesulfonamide,
IDI1_000543,
N1-2(1H)-pyrimidinylidene-sulfanilamide,
NCGC00016305-02,
NCGC00016305-03,
NCGC00016305-04,
NCGC00016305-05,
NCGC00016305-06,
NCGC00016305-10,
NCGC00023291-03,
NCGC00023291-04,
SULFADIAZINE (TRISULFAPYRIMIDINES),
2-(4-Aminobenzenesulfonylamino)pyrimidine,
AC-26817,
AK321973,
H458,
ST059447,
Sulfanilamide, N1-2-pyrimidinyl- (8CI),
ZB004097,
Mixture of sulfadiazine, and sulfamethazine,
SBI-0051520.P003,
AB2000282,
LS-147838,
4-[[(Pyrimidin-2-yl)amino]sulfonyl]aniline,
4-Amino-N-2-pyrimidinyl- benzenesulfonamide,
AB00052095,
Benzenesulfonamide,4-amino-N-2-pyrimidinyl-,
FT-0674741,
R3929,
S0579,
ST51006797,
SW196657-3,
TL80073596,
4-amino-N-(2-pyrimidinyl) benzenesulfonamide,
4-Amino-n-(2-pyrimidinyl)benzene-sulfonamide,
4-Amino-N-(2-pyrimidinyl)benzenesulfonamide #,
68S359,
C07658,
D00587,
Trisulfapyrimidine, oral suspension (Salt/Mix),
AB00052095-13,
AB00052095-14,
AB00052095_15,
AB00052095_16,
Benzenesulfonamide, 4-amino-N-(2-pyrimidinyl)-,
Sulfadiazine, VETRANAL(TM), analytical standard,
Q-201759,
SR-01000002973-2,
SR-01000002973-3,
BRD-K32273377-001-05-4,
BRD-K32273377-001-09-6,
I01-15838,
F1657-1720,
I14-110269,
Sulfadiazine, certified reference material, TraceCERT(R),
Z271004844,
Sulfadiazine, European Pharmacopoeia (EP) Reference Standard,
Sulfadiazine, United States Pharmacopeia (USP) Reference Standard,
Sulfadiazine, Pharmaceutical Secondary Standard; Certified Reference Material,
141582-64-1,
Sulfadiazine for identification of impurity F, European Pharmacopoeia (EP) Reference Standard,
Sulfazin,
Sulfacombin,
Soludiazine,
Lantrisul,
Sulfaloid,
Suthogen,
sulfadiazin-,
Sulfonamide Duplex,
Triple Sulfoid,
Diazyl (VAN),
Mixture Name,
Sodium sulfadiazine,
Sulfadiazine, Zinc,
Neotrizine (TN),
Solfadiazina sodica,
Sulfadiazin-natrium,
Sulfadiazina sodica,
Lantrisul (TN),
Sulfaloid (TN),
Sulfa-Triple #2,
Terfonyl (TN),
Soluble sulfadiazine,
Sulfadiazine sodique,
Sulfose (TN),
Sodium sulfapyrimidine,
Sulfadiazinum natricum,
Triple Sulfa (TN),
Triple Sulfas (TN),
Triple Sulfoid (TN),
2-Sulfanilamidopyridine,
SULFADIAZINE SODIUM,
Sulfonamides Duplex (TN),
Sulfa-Triple #2 (TN),
D05LKP,
Solfadiazina sodica [DCIT],
C10H10N4O2S.Na,
UNII-84CS1P306F,
component of Sulfonamide Duplex,
Sulfonamide Duplex (Salt/Mix),
Sulfadiazine sodium [USP:INN],
Sulfadiazine sodium [USAN:INN],
CID5215,
Sulfadiazina sodica [INN-Spanish],
Sulfadiazine sodique [INN-French],
Monosodium 2-sulfanilamidopyrimidine,
Sulfadiazinum natricum [INN-Latin],
C10-H10-N4-O2-S.Na,
EINECS 208-919-0,
2-Sulfanilamidopyrimidine sodium salt,
AN-160,
AR-1L4215,
C10-H10-N4-O2-S,
CS-O-02298,
NSC 117870,
Sulfadiazine, 99% - 100G 100g,
Sulfanilamide, N1-2-pyrimidinyl-(8CI),
A8527,
Bencenosulfonamida, 4-amino-n-2-pirimidinil-,
N1-2-Pyrimidinylsulfanilamide monosodium salt,
Sodium, (N(sup 1)-2-pyrimidinylsulfanilamido)-,
D013411,
N(sup 1)-2-Pyrimidinylsulfanilamide monosodium salt,
SDA,
Sulfanilamide, N(sup 1)-2-pyrimidinyl-, monosodium salt,
Mixture of sulfadiazine, sulfamerazine, and sulfamethazine,
Benzenesulfonamide, 4-amino-N-2-pyrimidinyl-, monosodium salt,
Adiazin;Adiazine;Debenal;Liquadiazine;Microsulfon;Sulfazine;Sulfolex,
Bencenosulfonamida, 4-amino-N-2-pirimidinil-, sal de sodio (1:1),
Sulfanilamide, N(sup 1)-2-pyrimidinyl-, N(sup 1)-sodium deriv,
116-44-9,
SDZ,
Adiazin, Adiazine, Debenal, Liquadiazine, Microsulfon, Sulfazine, Sulfolex, Sulfadiazine,
547-32-0,
6938-59-6,
|
| Complexity | 327 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 250.052g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 17 |
| Hydrogen Bond Acceptor Count | 6 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 250.276g/mol |
| Monoisotopic Mass | 250.052g/mol |
| Rotatable Bond Count | 3 |
| Topological Polar Surface Area | 106A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | -0.1 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H315-H319-H332-H335 |
| Packing Group | |
| Precautionary statements | P280-P305+P351+P338-P310 |
| UN Code | \N |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

